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Review Article
Complications associated with Cerebral Venous Thrombosis
Fazeel Mukhtar Siddiqui, Ayeesha K. Kamal
Department Of Medicine, The Aga Khan University Hospital, Karachi.

Abstract
Although CVT is associated with a good outcome in
the majority of cases, it may be complicated by numerous
unique and sometimes rare complications. The purpose of
this review is to discuss the acute and chronic complications
of CVT in greater detail. Awareness may lead to a more
aggressive approach in those in which these complications
are anticipated and perhaps avoided.
The complications of CVT may be temporally divided into those unique to the acute stage and those that are
associated with the chronic stage of CVT. They are venous
infarction and haemorrhage, subarachnoid haemorrhage, a
rapid progression and pulmonary embolism. In the chronic
stages of CVT, one may encounter dural AV - fistula, progressive psychiatric disease, residual epilepsy and recurrence. Cerebral venous sinus thrombosis is associated with
unique acute and chronic complications, some of them may
be avoidable e.g. pulmonary embolism. The chronic complications are rare but are potentially treatable e.g. dural
AVFistula nidus obliteration with intervention.

Acute Complications
Venous infarction and haemorrhage is the most common and well-recognized complication of sinovenous
thrombosis.

sion, if promptly diagnosed and adequately managed, contains reversible alterations and need not always lead to
venous infarction.
The rate of thrombosis is also an important factor
in the evolution of venous infarction.4 It may be acute and
stroke-like or it may be gradual, allowing time for the development of collateral venous circulation, which may protect
against venous infarction or limit its extension.
The infarction due to CVST is frequently haemorrhagic with accompanied bleeding in subarachnoid and subdural spaces as discussed in detail later. The reason behind
this haemorrhagic predisposition is probably the same elevated venous and capillary pressure due to persistent thrombus. Pale venous infarcts may occur, which do not conform
to an arterial territory. Because of the increased venous
pressure, there is early swelling of the infarct and adjacent
brain.
CVST particularly thrombosis of internal cerebral
veins is also a potential risk factor for neonatal intraventricular haemorrhage and periventricular leukomalacia, particularly when the infant is near term and has bilateral haemorrhagic lesions as described by Ehlers H, Courville CB
(1936).5

Venous infarction and haemorrhage

The treatment of venous haemorrhagic infarct differs from its arterial counterpart over the issue of the use of
anticoagulants.

Parenchymal oedema with venous infarction and
haemorrhage, complicates about10-50% of cases, principally affecting the cortex and adjacent white matter.1
Haemorrhagic infarcts are included in bad prognostic indicators of CVST by 'International Study on Cerebral Vein
and Dural Sinus Thrombosis (ISCVT)'.2

Subarachnoid Haemorrhage

The Pathophysiology of venous infarction is
thought to be primarily due to elevated venous and capillary
pressure caused by the persistence of thrombosis.3
Extensive collateral circulation within the cerebral venous
system allows for a significant degree of compensation in
the early stages of venous occlusion. Elevated cerebral
venous pressure due to cerebral venous occlusion can result
in a spectrum of phenomena including a dilated venous and
capillary bed, development of interstitial oedema, increased
cerebrospinal fluid production, decreased cerebrospinal
fluid absorption and rupture of venous structures
(haematoma). All of these pathophysiological changes may
explain the clinical observation that cerebral venous occlu-
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After the separate trials conducted by Einhaupl6
and De Bruijn7 there is general agreement that intravenous
heparin should be the first-line treatment of CVST, even in
the presence of haemorrhagic infarction, provided there are
no general contraindications to its use.

The presentation of CVST sometimes greatly mimics subarachnoid haemorrhage. Thunderclap headache, typical of subarachnoid haemorrhage is reported in more than
10% of cases. Seizures and hemi-paresis, possible manifestations of subarachnoid haemorrhage, occur in about one
third of cases with CVST. Rarely, CTscan may show a subarachnoid haemorrhage and patients with CVST may present with both clinical and radiologic features which mimic
an acute subarachnoid haemorrhage from a bleeding
aneurysm. It is important to establish whether subarachnoid
haemorrhage is due to CVST, as this requires a completely
different treatment from subarachnoid haemorrhage due to
a leaking aneurysm.
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The pathophysiology is similar to venous infarction
with raised venous pressure due to persistent thrombus leading to rupture of a dilated tributary vein of an involved
sinus.8 As superior Sagittal sinus is the most frequent
involvement in CVST, so Sylvian vein is the usual culprit.
Oppenheim et al.9 Zare et al.10, Shukla et al. (JAPI 2006).11
The result is the involvement of sulci of the convexity and
sparing of the basal cisterns. The irritative effect of blood
in sulci leads to the symptoms of focal seizure and hemiparesis. There is only one case report published on the
involvement of posterior circulation.12
As
in
case
of
venous
haemorrhagic
infarction,although the literature is sparse, there are reports
of the use of heparin in this situation with relative safety.8,10,12 There is a special condition pointed out in a
Japanese case report when SAH occurs in a patient of CVST
complicated with multiple aneurysms and it becomes quite
confusing to decide the cause of haemorrhage as well as the
timing of surgery for aneurysms.11 They recommend that in
SAH cases, the venous phase should be examined at least in
one side of the carotid arteries to avoid such confusion.

Pulmonary Embolism
It is an uncommon complication but has poor prognostic implication as described by 2ISCVT. A review of literature between 1942 and 1990 by Diaz et al.13 revealed that
in 11.3% cases CVST was associated with pulmonary
embolism and in these cases the overall mortality rate was
95.6%, far higher than in those without embolism. They
found out that even in the absence of systemic thromboses,
the occurrence of pulmonary embolism strongly suggests
dislodgment from cerebral venous sinus system. Superior
Sagittal sinus appeared to be the most important source.
Other thrombotic events like involvement of calf
veins, pelvic veins, hepatic veins, and/or extra cranial veins
also occur. According to Bousser in his follow up of 77
patients, proven thrombotic events other than sinovenous
thrombosis occurred in 14% of CVST patients.14 This systemic thrombosis can be an independent source of pulmonary embolism. Thus, the prevention of pulmonary
embolism is probably an important ancillary benefit of anticoagulation in patients with CVST, particularly patients
with an identified predisposition to thrombus formation.

Rapidly Progressive Illness and coma
This is a very rare occurrence, usually associated
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with the extensive involvement of deep cerebral venous system.15 The classic picture is that of a child with an acute
coma associated with decerebrate decortication, extrapyramidal hypertonia, signs of raised intracranial pressure,
papillary changes, and rise in blood pressure leading to
death in a few hours or days. Similar cases are reported in
adults. When patients survive, severe sequelae, such as akinetic mutism, mental retardation, dementia, bilateral
athetoid movement, hemi-paresis, vertical gaze palsy, and
dystonia are common.
Rapidly progressive state can also arise due to extension of thrombosis leading to complete occlusion of the
superior sagittal sinus (SSS) and right transverse/sigmoid
sinus complex.16 The presentation is usually a history of
several days of illness with severe headache and photophobia that changes its course to a rapid deterioration and coma.
If large unilateral infarcts or haemorrhages compress
the diencephalons and brain stem; patients may become
comatose or die from cerebral herniation if untreated. Other
causes of coma are involvement of the thalamus and generalized seizures.17
ISCVT regards coma as one of the poor prognostic
indicators and involvement of deep cerebral veins as variable indicating dependency and increase risk of death.2
Due to poor prognosis, aggressive measures are
favoured in this setting. In the rare patient who develops
coma, fixed and dilated pupils, and brain herniation, early
intervention by emergency decompressive craniectomy may
be helpful.18
Surgical thrombectomy or microsurgical revascularization with venous bypass for aseptic lateral sinus thrombosis and superior sagittal sinus thrombosis may be considered in patients with a rapidly progressive course despite
appropriate medical therapy. Use of attractive techniques
like Microsnare, AngioJet, intravascular laser and intravascular ultrasound for thrombus disruption are still experimental.4
One additional method of clot disruption is to perform balloon angioplasty within the clot to disrupt it and
facilitate the effect of the thrombolytic agent.4,16 This technique may be helpful in patients with rapid clinical worsening and extensive thrombosis. The balloon may also be
inflated in the clot and used to pull the clot into the jugular
vein, such as is done in peripheral vascular diseases
(Fogarty technique).
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Complications due to cavernous involvement
There are certain complication specific for cavernous sinus thrombosis. A Korsakoff-like amnestic syndrome with confabulation has been described with bilateral
mesial temporal lobe infarction following bilateral cavernous sinus thrombosis.4 Furthermore, thrombosis of the
cavernous sinus may be associated with the syndrome of
inappropriate antidiuretic hormone secretion (SIADH) from
effects on the nearby pituitary and in extreme cases can lead
to hypopituitarism.19 Ocular oedema and/or compression of
optic nerve may result in blindness.4 Inter-cavernous internal carotid artery may be involved leading to hemi-paresis.4
Early institution of antibiotics is mandatory for minimizing
complications, as the usual cause of cavernous sinus thrombosis is infection.4

Other rare acute complications
Other rare acute complications of CVST include
bilateral subdural effusion as reported in three cases by
Marquardt et al.21, and intracranial hypotension in cases of
extended dural sinus thrombosis.
Mosa et al22 describe a rare syndrome called
Syndrome of blindness, ophthalmoplegia and extensive
radiculopathy in two cases characterized by acute bilateral
visual loss, complete internal and external ophthalmoplegia,
and areflexic flaccid quadriparesis with normal sensorium
along with raised ICP. The possible cause is raised intracranial pressure due to CVST. Early and aggressive measures
to decrease ICP led to marked recovery in both cases.

Chronic Complications
Development of AV fistula
Development of AV fistula is the most interesting
though rare chronic complication of CVST.23 There is a
clear-cut association between CVST and dural arteriovenous fistulas, although it may be difficult in some cases to
ascertain if the thrombosis was a primary or secondary
event. According to Tripathi et al.24, DAVFs can be classified into two major groups: cavernous sinus DAVFs (CSDAVFs) and noncavernous sinus DAVFs (NCS-DAVFs).
Approximately 30% of symptomatic intracranial DAVFs
involve the transverse and sigmoid sinuses. Tsai et al.23 in
his analysis of 69 patients of DAVFs states that out of 69,
the most frequent location of Dural AVF was the cavernous
sinus (21 (30%)), followed by the skull base (13 (19%)),
transverse sinus (12 (17%)), Dural convexity (8 (12%)), sigmoid sinus (7 (10%)), torcular Herophili (5 (7%)), and superior sagittal sinus (3 (4%)). Symptoms depend upon the
location of AV fistulas.
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DAVFs due to CVST are uncommon in young children with atypical clinical presentation representing with
prematurity and delayed milestones with childhood hemiplegia as described by Tripathi in a case report. Confusion
can be created by the possibility of a sequel of hypoxicischemic encephalopathy or a TORCH infection.24
Two hypotheses have been proposed for the pathogenesis of Dural AVF.23 The first is based on the physiological arteriovenous shunts between the meningeal arterial
networks and the dural venous sinuses. An increase in sinus
and venous pressure-for example, by the obstruction of
venous outflow by CVST, may open these channels to create Dural AVFs. The second hypothesis, as shown in the rat
model, suggests that venous hypertension induced by an
obstruction to venous outflow may reduce cerebral perfusion and lead to ischemia, followed by angiogenesis. The
aberrant angiogenic activity of the Dural blood vessels
would then result in arteriovenous shunting. In both, CVST
may be the primary event that caused the venous hypertension. The occurrence of secondary thrombotic event is also
a possibility probably because of the turbulent flow into the
venous sinus due to DAVFs.
Hung-Yi et al. in a case study described Serial
Venous Transcranial Color-Coded Sonography as a useful
technique for detecting disturbance of cerebral venous circulation and for follow-up of patients with cerebral venous
sinus thrombosis.25 Valuable information such as flow
direction and changes in the Doppler flow waveform, which
cannot be routinely obtained by time-of-flight MR angiography, can be recorded easily and noninvasively with
venous TCCS. Although TCCS cannot examine all the
intracranial venous structures, it can serve as a complementary examination technique, providing hemodynamic information on venous circulation.
Regarding treatment of DAVFs, it is a highly challenging subject. Intrasinus stenting can be helpful for relieving elevated sinus pressure but may lead to a greater arteriovenous pressure gradient and shunt flow. Arterial
embolization of a DAVF without relief of venous hypertension can give rise to another fistula.
Techniques like, intermittent carotid arterial compression25, Percutaneous intraarterial embolization using
detachable balloons26, isobutylcyanoacrylate, or polyvinyl
alcohol particles, transvenous embolization with coils or
liquid adhesives27, and surgeries like venous bypass using
saphenous vein28 and gamma knife stereotactic surgery25
are used in different cases.
Controlled hypotension can also become an alternative for treatment of DAVF in high-risk patients or when
there is no chance for embolization.29
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Residual epilepsy

pholipid syndrome.

Seizures are observed only in patients who had
seizures and focal signs in the acute stage, and only in a
minority. It has been reported in 10% to 30% of patients
who had seizures during the acute stage. Out of a follow up
of 77 patients, 4 had residual epilepsy in Preter et al. analysis while 7 out of 57 patients suffered recurrences in a
French study.30

Most authors recommend using oral anticoagulation
for 3 to 6 months at which time they should be reevaluated
with MRI/MRV. Prolonged anticoagulation may be required
for refractory cases or for patients with an identified prothrombotic state. In the above-described case life long anticoagulation was started.

Seizures usually occur in the first year and are easily controlled with antiepileptic drugs. Preter et al. recommend that due to low occurrence of seizures it is appropriate to maintain anticonvulsant therapy for a year and to
taper off gradually thereafter. If seizures recur, anticonvulsants should be given on a long-term basis.
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